ResearcherThe University of QueenslandActive in the last 2 years
David Cavallucci
Matched on ORCID iD 0000-0003-2112-6465; OpenAlex author ID A5040125298. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers
Papers 6
- Indocyanine Green-Labeled Antibodies Cotargeting CDCP1 and Mesothelin for Fluorescence-Guided Imaging of Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.5c01452↗
- 68Ga-FAPI-46 PET/CT Versus 18F-FDG PET/CT for Pancreatic Cancer: A Feasibility Study. Co-author DOI 10.1111/1754-9485.70124↗
- Synoptic Multidisciplinary Team Meeting Workflows to Promote Guideline-Based Classification of Resectability in Pancreatic Cancer: A Multicenter Prospective St… Last author DOI 10.1200/cci-25-00255↗
- 68Ga-FAPI PET/CT Prevents Futile Surgery and Demonstrates Tumor Biology in Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.2967/jnumed.125.270510↗
- Fibroblast Activation Protein Is Overexpressed on Both Stromal and Epithelial Cells Before Pancreatic Ductal Adenocarcinoma: Implications for Early Diagnosis o… Co-author DOI 10.1053/j.gastro.2024.06.033↗
- Pentixafor as a theranostic agent in rectal and pancreatic adenocarcinoma: outcomes from a pilot study Co-author DOI 10.21203/rs.3.rs-1274952/v2↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- William T. McGahan · 4 shared papers, 2024–2026 · strength 1.14
- Paper Synoptic Multidisciplinary Team Meeting Workflows to Promote Guideline-Based Classification of Resectability in Pancrea… DOI 10.1200/cci-25-00255↗
- Paper Indocyanine Green-Labeled Antibodies Cotargeting CDCP1 and Mesothelin for Fluorescence-Guided Imaging of Pancreatic Can… DOI 10.1021/acs.molpharmaceut.5c01452↗
- Paper 68Ga-FAPI PET/CT Prevents Futile Surgery and Demonstrates Tumor Biology in Patients with Pancreatic Ductal Adenocarcino… DOI 10.2967/jnumed.125.270510↗
- John David Hooper · 2 shared papers, 2024–2026 · strength 0.48
- Paper Indocyanine Green-Labeled Antibodies Cotargeting CDCP1 and Mesothelin for Fluorescence-Guided Imaging of Pancreatic Can… DOI 10.1021/acs.molpharmaceut.5c01452↗
- Paper Fibroblast Activation Protein Is Overexpressed on Both Stromal and Epithelial Cells Before Pancreatic Ductal Adenocarci… DOI 10.1053/j.gastro.2024.06.033↗
- Nicholas O’Rourke · 2 shared papers, 2022–2026 · strength 0.46
- Nicola Evans · 1 shared paper, 2026 · strength 0.32
- David Wong · 1 shared paper, 2026 · strength 0.32
- Johnny X. Huang · 1 shared paper, 2026 · strength 0.32
- Jaswinder Singh Samra · 1 shared paper, 2024 · strength 0.17
- Marina Pajic · 1 shared paper, 2024 · strength 0.17
- Anthony James Gill · 1 shared paper, 2024 · strength 0.17
- Thomas Kryza · 1 shared paper, 2024 · strength 0.17
- Elizabeth Stephanie Ahern · 1 shared paper, 2022 · strength 0.14
- Matthew Burge · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.